Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-23-000264
Filing Date
2023-06-20
Accepted
2023-06-20 17:01:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2959
  Complete submission text file 0001968582-23-000264.txt   4344
Mailing Address C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address
Hambleton Julie (Reporting) CIK: 0001578771 (see all company filings)

Type: 144

Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Subject) CIK: 0001773427 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39044 | Film No.: 231026102
SIC: 2836 Biological Products, (No Diagnostic Substances)